000 | 01713cam a2200325 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
008 | 140517s2013 ua d f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aM.Sc | ||
099 | _aCai01.11.06.M.Sc.2013.Ib.R | ||
100 | 0 | _aIbrahim AbouElkhair Hassan Montasser | |
245 | 1 | 0 |
_aRelationship between severity of asthma and high sensitivity C- reactive protein / _cIbrahim Abouelkhair Hassan Montasser ; Supervised Mohammed Galal Morsi , Mohammed Shehata , Hassan Mahmoud Amen |
246 | 1 | 5 | _aدراسة العلاقة بين شدة الربو الشعبى و البروتين التفاعلى- سى عالى الحساسية |
260 |
_aCairo : _bIbrahim Abouelkhair Hassan Montasser , _c2013 |
||
300 |
_a144 P. : _bcharts ; _c25cm |
||
502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Chest Diseases and Tuberculosis | ||
520 | _aHS-CRP may be used to assess the severity of the disease and response to treatment. Hs-CRP may be used as a systemic marker of inflammatory process that occurs in patients with asthma. HS-CRP level is recommended to be studied as a marker for development of exacerbation of asthma. HS-CRP level is recommended to be studied as follow up marker during treatment with ICS in stepwise management of asthma | ||
530 | _aIssued also as CD | ||
653 | 4 | _aBSCRP | |
653 | 4 | _aC- reactive protein | |
653 | 4 | _aSeverity of asthma | |
700 | 0 |
_aHassan Mahmoud Amen , _eSupervisor |
|
700 | 0 |
_aMohammed Galal Morsi , _eSupervisor |
|
700 | 0 |
_aMohammed Shehata , _eSupervisor |
|
905 |
_aNazla _eRevisor |
||
905 |
_aSamia _eCataloger |
||
942 |
_2ddc _cTH |
||
999 |
_c46083 _d46083 |